Rotta Denise, Fassio Angelo, Rossini Maurizio, Giollo Alessandro, Viapiana Ombretta, Orsolini Giovanni, Bertoldo Eugenia, Gatti Davide, Adami Giovanni
Rheumatology Unit, University of Verona, Verona, Italy.
Front Med (Lausanne). 2020 Dec 1;7:613720. doi: 10.3389/fmed.2020.613720. eCollection 2020.
Osteoporosis is a skeletal disorder characterized by impaired bone strength and increased risk of fragility fracture and is among the most relevant comorbidities of rheumatic diseases. The purpose of the present review is to discuss the pathogenesis of local and systemic bone involvement in inflammatory arthritides, especially Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritides, as well as the effect of anti-rheumatic treatments and anti-osteoporotic medication on bone health and fracture incidence, including recent data on novel therapeutic perspective.
骨质疏松症是一种以骨强度受损和脆性骨折风险增加为特征的骨骼疾病,是风湿性疾病最相关的合并症之一。本综述的目的是讨论炎症性关节炎,特别是类风湿关节炎、银屑病关节炎和脊柱关节炎中局部和全身骨骼受累的发病机制,以及抗风湿治疗和抗骨质疏松药物对骨骼健康和骨折发生率的影响,包括关于新治疗前景的最新数据。